The Effect of Mindfulness-Based Breathing Exercises on Symptom Control
ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorFirat University
About this trial
This randomized controlled experimental study aims to evaluate the effect of mindfulness-based breathing exercises on symptom management and salivary cortisol levels in breast cancer patients receiving chemotherapy. The study population will consist of breast cancer patients undergoing chemotherapy treatment in the Oncology Department of Fırat University Hospital. A total of 72 patients who meet the inclusion criteria and volunteer to participate will be included in the study, with 36 patients in the experimental group and 36 in the control group. Data will be collected using the Personal Information Form and the Edmonton Symptom Assessment Scale. The findings of this study are expected to provide evidence regarding the effectiveness of mindfulness-based breathing exercises in improving symptom management and reducing stress levels in breast cancer patients receiving chemotherapy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Being over 18 years of age
Knowing their diagnosis
Receiving chemotherapy for the first time due to a breast cancer diagnosis
Having breast cancer stages I, II, or III (stage 4 patients were not included in the study as metastatic spread would increase symptoms and make communication with the patient difficult),
Disqualifiers
Patients with communication problems • Patients with psychiatric problems
Trial design
Design model
Parallel
Treatments tested in this trial
Mindfulness-Based Breathing Exercise
BehavioralMindfulness-based breathing exercises focusing attention on breathing to promote awareness and support symptom management in breast cancer patients receiving chemotherapy.
Treatment groups
72 Participants
are divided into 2 treatment groupsGroup A: Experimental GroupExperimental treatment 1 intervention
Group B: Control GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Symptom Severity
Evaluation of symptom severity in breast cancer patients receiving chemotherapy using the Edmonton Symptom Assessment Scale (ESAS).
Time frame
Baseline and after the intervention period (e.g., 8 weeks)Secondary outcomes
1
Salivary Cortisol Level
Assessment of stress level by measuring salivary cortisol levels in breast cancer patients undergoing chemotherapy.
Time frame
Baseline and after the intervention period (e.g., 8 weeks)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov